A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

PHASE3RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Secondary HyperparathyroidismChronic Kidney Disease
Interventions
DRUG

Etelcalcetide

Etelcalcetide has been shown to be safe and efficacious in treating adult CKD patients with SHPT by simultaneously controlling intact parathyroid hormone (iPTH), Ca, and phosphorus and has recently been approved for use in adult patients with SHPT treated with hemodialysis in both the United States and Europe

Trial Locations (43)

4000

RECRUITING

Centro Infantil Del Rinon, San Miguel de Tucumán

10029

COMPLETED

Mount Sinai Kidney Center - B1 Renal Treatment, New York

10041

RECRUITING

National Taiwan University Hospital, Taipei

15586

TERMINATED

Hospital Raja Perempuan Zainab II, Kota Bharu

19104

RECRUITING

Childrens Hospital of Philadelphia, Philadelphia

23200

RECRUITING

Firat Universitesi Hastanesi, Elâzığ

33305

RECRUITING

Linkou Chang Gung Memorial Hospital, Taoyuan District

34098

RECRUITING

Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul

34890

RECRUITING

Marmara Universitesi Tip Fakultesi Hastanesi, Istanbul

35040

RECRUITING

Ege Universitesi Tip Fakultesi Hastanesi, Izmir

38039

RECRUITING

Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

45229

COMPLETED

Cincinnati Childrens Hospital Medical Center, Cincinnati

50300

TERMINATED

Hospital Wanita Dan Kanak-Kanak Kuala Lumpur, Kuala Lumpur

50612

TERMINATED

Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnam-do

64108

RECRUITING

Childrens Mercy Hospital, Kansas City

70300

TERMINATED

Hospital TuanKu Jaafar, Seremban

70403

TERMINATED

National Cheng Kung University Hospital, Tainan City

73104

COMPLETED

The Childrens Hospital at Oklahoma University Medical Center, Oklahoma City

75390

TERMINATED

Childrens Medical Center Dallas, Dallas

80045

TERMINATED

Childrens Hospital Colorado, Aurora

81362

RECRUITING

Kaohsiung Veterans General Hospital, Kaohsiung City

84113

RECRUITING

Primary Childrens Hospital Outpatient Services, Salt Lake City

90027

RECRUITING

Childrens Hospital of Los Angeles, Los Angeles

107014

TERMINATED

SBHI Pediatrics city clinical hospital of Saint Vladimir, Moscow

110029

RECRUITING

All India Institute of Medical Sciences, New Delhi

110060

RECRUITING

Sir Ganga Ram Hospital, New Delhi

119074

RECRUITING

National University Hospital, Singapore

198205

RECRUITING

SBHI Children's City Multidisciplinary Clinical Specialized Center of High Medical Technologies, Saint Petersburg

443095

TERMINATED

State Budgetary Healthcare Institution Samara Regional Clinical Hospital na V D Seredavin, Samara

590010

RECRUITING

KLES Dr Prabhakar Kore Hospital and Medical Research Centre, Belagavi

700014

RECRUITING

NRS Medical College and Hospital, Kolkata

B1625DUG

TERMINATED

Fresenius Escobar, Belén de Escobar

C1199ABB

RECRUITING

Hospital Italiano, Cuidad Autonoma de Buenos Aires

560 017

RECRUITING

Manipal Hospital, Bangalore

110 070

RECRUITING

Fortis Flt Lt Rajan Dhall Hospital, New Delhi

05505

TERMINATED

Asan Medical Center, Seoul

110-744

TERMINATED

Seoul National University Hospital, Seoul

06230

RECRUITING

Hacettepe Universitesi Tip Fakultesi Hastanesi, Ankara

06490

RECRUITING

Baskent Universitesi Ankara Hastanesi, Ankara

06500

RECRUITING

Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi Gazi Hastanesi, Ankara

06800

RECRUITING

Ankara Bilkent Sehir Hastanesi, Ankara

01135

TERMINATED

National Childrens Specializated Hospital Okhmadit, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT03633708 - A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis | Biotech Hunter | Biotech Hunter